PMID: 7543204Feb 1, 1995Paper

Design of four-helix bundle protein as a candidate for HIV vaccine

Protein Engineering
A M EroshkinG M Ignat'ev

Abstract

To be efficient, a synthetic vaccine should contain different T and B cell epitopes of human immunodeficiency virus (HIV) antigens, and the B epitope regions in the vaccine and in the HIV should be conformationally similar. We have suggested previously the construction of vaccines in the form of a protein with a predetermined tertiary structure, namely a four-alpha-helix bundle. Antigenic determinants of cellular and humoral immunity are blocks for the vaccine design. From experimentally studied HIV-1 T and B cell epitopes, we constructed a sequence of a four-helix protein TBI (T and B cell epitopes containing immunogen). The gene of the protein was synthesized and the protein was produced in C600 Escherichia coli cells under recA promoter from Proteus mirabelis. CD spectroscopy of the protein demonstrated that 30% of amino acid residues adopt an alpha-helical conformation. Mice immunized with TBI have shown both humoral and cellular immune responses to HIV-1. The obtained data show that the design of TBI was successful. The synthesized gene structure makes possible further reconstruction and improvement of the protein vaccine structure.

Citations

Jan 26, 1996·Journal of Biotechnology·V B LoktevL S Sandakhchiev
Apr 13, 1999·Infectious Disease Clinics of North America·S E Frey
Oct 6, 2000·Journal of Molecular Graphics & Modelling·D GrellM Mutter
Jun 6, 2007·Doklady. Biochemistry and Biophysics·L I KarpenkoL S Sandakhchiev
Feb 22, 2012·Molecular Immunology·Larisa I KarpenkoAlexander A Ilyichev
Mar 19, 2015·PloS One·Anton N ChikaevAlexander A Ilyichev

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.